Long-term cognitive impact of anticholinergic medications in older adults.
about
Anticholinergics versus placebo for neuroleptic-induced parkinsonismAnticholinergics (various) for neuroleptic-induced parkinsonismSerum Anticholinergic Activity and Cognitive and Functional Adverse Outcomes in Older People: A Systematic Review and Meta-Analysis of the LiteratureDrugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population: the 3-city study.Dopamine D2 receptor occupancy and cognition in schizophrenia: analysis of the CATIE data.Cognitive slowing associated with elevated serum anticholinergic activity in older individuals is decreased by caffeine use.Cognitive decline in older persons initiating anticholinergic medications.High postoperative serum cortisol level is associated with increased risk of cognitive dysfunction early after coronary artery bypass graft surgery: a prospective cohort study.Use of CNS medications and cognitive decline in the aged: a longitudinal population-based studyCNS medications as predictors of precipitous cognitive decline in the cognitively disabled aged: a longitudinal population-based studyAntidepressant Use and Cognitive Decline: The Health and Retirement StudyThe Influence of Patient Characteristics on Anticholinergic Events in Older People.Long-term anticholinergic use and the aging brain.The neuropsychology of cannabis and other substance use in schizophrenia: review of the literature and critical evaluation of methodological issues.Neurocognitive costs and benefits of psychotropic medications in older adults.The cognitive impact of anticholinergics: a clinical review.Association Between Anticholinergic Medication Use and Cognition, Brain Metabolism, and Brain Atrophy in Cognitively Normal Older AdultsDrugs with anticholinergic properties: a potential risk factor for psychosis onset in Alzheimer's disease?A systematic review of amnestic and non-amnestic mild cognitive impairment induced by anticholinergic, antihistamine, GABAergic and opioid drugs.Anticholinergic drug burden in older people's brain - how well is it measured?Enabling a multidisciplinary approach to the study of ageing and Alzheimer's disease: an update from the Australian Imaging Biomarkers and Lifestyle (AIBL) study.Impact of anticholinergic discontinuation on cognitive outcomes in older people: a systematic review.Anticholinergic drugs and negative outcomes in the older population: from biological plausibility to clinical evidence.Detailed cognitive function and use of drugs with anticholinergic properties in older people: a community-based cross-sectional study.Examination and Estimation of Anticholinergic Burden: Current Trends and Implications for Future Research.Anticholinergic Drug Use and Risk to Cognitive Performance in Older Adults with Questionable Cognitive Impairment: A Cross-Sectional Analysis.Potentially inappropriate medication use is associated with clinical outcomes in critically ill elderly patients with neurological injury.Comparison of frailty among Japanese, Brazilian Japanese descendants and Brazilian community-dwelling older women.Role of anticholinergic burden in primary care patients with first cognitive complaints.Association between using medications with anticholinergic properties and short-term cognitive decline among older men: A retrospective cohort study in Taiwan.Factors associated with appropriate psychotropic drug prescription in nursing home patients with severe dementia.Cognitive performance of long-term institutionalized elderly patients with schizophrenia: A case control study.Anticholinergics influence transition from normal cognition to mild cognitive impairment in older adults in primary care.Effects of anticholinergic drugs on cognitive function in older Australians: results from the AIBL study.Anticholinergic drug use and cognitive performances in middle age: findings from the CONSTANCES cohort
P2860
Q24194301-0CBBEB22-CC90-4B6A-A256-62A4151610AFQ24194831-6C672B5C-7129-429C-8F5F-4103EDC5F7F3Q26752928-0D6E67A8-297C-4273-95CD-46070792857DQ34104256-F8E14611-5592-405A-AB83-1E58192E60DFQ34145251-5C72421C-887C-4F64-9E88-12A8EDB8BCC9Q34400362-0C2D6245-F46D-4641-A824-F57AA7B37616Q34760402-02394CFA-E5F5-46B0-A698-BE774E89EBEBQ35021806-9CB4E454-66DE-46D5-8230-3DB42597BB2FQ35580037-41F87E7C-2819-427B-A7EE-47CEC8C6FF11Q35953332-BD82CD8D-3A70-4043-8E89-53AF68D44F31Q36201714-13591685-4E0A-4190-B200-F8BD1278209CQ36650690-BF618D5C-FBB6-4D79-B475-247DB83A4640Q36906645-81B46054-E490-45EA-8B89-CE03F2C7EDD4Q36965847-4EA521DA-BA0C-4DE1-A94C-CE401CA6FCB6Q37001163-A605EE3B-1A15-49C5-8541-0E0A6D8FF26FQ37230472-02D79A02-BDCF-4990-8067-9903EC8A7458Q37268405-7471B7C1-744A-429C-BFC2-54EDA6B68395Q37529854-0819FB2B-79A0-48B3-AA7A-281161677DBAQ38027567-091227EE-A1D4-4440-96B3-F3E3F136BE61Q38151217-0DF8D883-8D98-43AE-B285-BFA964328E01Q38178373-E7AFB653-48BC-4A12-8638-C9EFDAB51F3DQ38187907-477F5392-5E9D-4DE6-997D-21752FCBBBC4Q38452282-7A5812B0-29B4-4413-92E8-8280514A0129Q38457002-89DD0DE0-C7D4-449B-A734-0CCD3719AA7BQ38886942-52C12B00-565A-46E9-9343-4E92C862120EQ39379518-BB92D236-F6E8-4A5F-A6D9-43B2CED93178Q44997797-A42B0902-BC24-4D64-96CB-2F95F792BA0CQ46113355-EE8A663B-E2BD-4206-A905-45060800FE4BQ47723092-2A49B116-9F33-47A1-86A5-48F90D4E15BEQ47741746-D8188266-9593-4609-AB02-9C8F66360744Q47763408-6E6C8127-C62F-49FA-A395-83526EA32D29Q50043548-5715A996-EB12-4D29-8E1B-E2F4AC7AB1D8Q51758193-3B6F47F9-72F9-484E-9A7E-B0625DA1CA1AQ53422654-DC2A3E3D-2BBC-43F4-93F7-474057F56E52Q57142285-69FC88EB-93B9-492B-A7A9-08DD73E137BE
P2860
Long-term cognitive impact of anticholinergic medications in older adults.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Long-term cognitive impact of anticholinergic medications in older adults.
@en
Long-term cognitive impact of anticholinergic medications in older adults.
@nl
type
label
Long-term cognitive impact of anticholinergic medications in older adults.
@en
Long-term cognitive impact of anticholinergic medications in older adults.
@nl
prefLabel
Long-term cognitive impact of anticholinergic medications in older adults.
@en
Long-term cognitive impact of anticholinergic medications in older adults.
@nl
P2093
P1476
Long-term cognitive impact of anticholinergic medications in older adults
@en
P2093
Allison M Caban-Holt
Frederick A Schmitt
Kara A Bottiggi
Marta S Mendiondo
Melody Ryan
P304
P356
10.1097/01.JGP.0000224619.87681.71
P577
2006-11-01T00:00:00Z